SCHEMBL6777820

SCHEMBL6777820

CS(=O)(=O)Nc1cccc2cc(C(=N)N(O)c3cccc(Cl)c3)oc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.40
NR3C1 P04150 4/20 0.38
MRGPRX1 Q96LB2 1/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
ALDH1A1 P00352 2/20 0.35
HTT P42858 2/20 0.35
USP2 O75604 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
HSP90AA1 P07900 1/20 0.35
KDM4E B2RXH2 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PGR P06401 2/20 0.35
NR3C2 P08235 2/20 0.35
AR P10275 2/20 0.35
PTGS1 P23219 2/20 0.34
PTGS2 P35354 2/20 0.34
RORC P51449 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7582051 0.85 GPR35 (0.41) MEN1KMT2AALDH1A1LMNAHSP90AA1
SCHEMBL7586241 0.78 HTR3E (0.40) MEN1KMT2AALDH1A1MAPTHSP90AA1
SCHEMBL7585802 0.77 LMNA (0.51) MEN1KMT2AALDH1A1HTTLMNA
SCHEMBL5867011 0.75 CTPS1 (0.42) KEAP1NR3C1MEN1KMT2AALDH1A1
SCHEMBL5867013 0.75 CTPS1 (0.42) KEAP1NR3C1MEN1KMT2AALDH1A1
SCHEMBL5867018 0.73 IDO1 (0.42) KEAP1NR3C1HTTLMNAPGR
SCHEMBL6086196 0.72 KCNQ2 (0.42) MEN1KMT2AALDH1A1HTTLMNA
SCHEMBL6086523 0.71 HTR3E (0.42) KMT2AALDH1A1KDM4ESMN1; SMN2HTR3E
SCHEMBL7586299 0.68 GPR35 (0.42) MEN1KMT2AALDH1A1HTTLMNA
SCHEMBL7591071 0.68 MAOB (0.47) KDM4EHTR3EHTR3BHTR3AHTR3D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6780858-B2 Antibacterial agents TULARIK INC. 2004-08-24 US disclosed
EP-1246795-A2 ANTIBACTERIAL AGENTS Tularik Inc. (US) 2002-10-09 EP disclosed
US-20020045749-A1 Antibacterial agents AMGEN INC. 2002-04-18 US disclosed
WO-2001051456-A2 ANTIBACTERIAL AGENTS TULARIK INC. (US) 2001-07-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020045749-A1 Antibacterial agents MRPL21, HDHD5, CLPP KEAP1 1861/4885NR3C1 4834/4885MRGPRX1 2953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.